EU-FMD Delegated Act: The wait is nearly over

The European Commission has published the notes from the 74^th meeting of the Pharmaceutical Committee, held on 17^th March 2015, that confirm that DG Sanco stands by the timeline that has been set out before. It is expected that the delegated act will be adopted – together with the relative impact assessment – by Q2 2015 and published in Q4 2015.
These dates are key as the adoption will finalise the details of what compliance with the EU-FMD requirement means and will therefore remove all lingering doubts as to what all participants in the European medicines supply chain – in particular pharmaceutical manufacturers – need to implement (3C Integrity, 2 April 2015).
Click here for the full article.
Click here to download the notes on the 74^th meeting of the Pharmaceutical Committee (84 kB).
Click here for more information about the NVC E-Course Pharmaceutical Packaging.

If you have any questions about this subject, please contact us: info@nvc.nl, +31-(0)182-512411. This item is also included in our monthly overview, the NVC Members-only Update.